Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other financing activities (2018 - 2025)

Historic Other financing activities for Bio (TELA) over the last 6 years, with Q3 2025 value amounting to $21000.0.

  • Bio's Other financing activities rose 1052.63% to $21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $212000.0, marking a year-over-year decrease of 4143.65%. This contributed to the annual value of $369000.0 for FY2024, which is 2768.17% up from last year.
  • According to the latest figures from Q3 2025, Bio's Other financing activities is $21000.0, which was up 1052.63% from $3000.0 recorded in Q2 2025.
  • In the past 5 years, Bio's Other financing activities registered a high of $3.2 million during Q2 2022, and its lowest value of $1000.0 during Q2 2023.
  • For the 4-year period, Bio's Other financing activities averaged around $301428.6, with its median value being $15000.0 (2024).
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 9996.88% in 2023, then soared by 100000.0% in 2024.
  • Quarter analysis of 4 years shows Bio's Other financing activities stood at $4000.0 in 2022, then changed by 0.0% to $4000.0 in 2023, then skyrocketed by 175.0% to $11000.0 in 2024, then soared by 90.91% to $21000.0 in 2025.
  • Its Other financing activities was $21000.0 in Q3 2025, compared to $3000.0 in Q2 2025 and $177000.0 in Q1 2025.